Top Markets
Coin of the day
I'rom Group Co., Ltd. I'rom Group Co., Ltd.

I'rom Group Co., Ltd.

2372
Rangering i aksjer #17926
I'rom Group Co., Ltd. is a Japanese enterprise specializing in several key... I'rom Group Co., Ltd. is a Japanese enterprise specializing in several key areas: pioneering advanced medical treatments, offering site management organization (SMO) services, acting as a contract research organization (CRO), and providing various forms of medical support. The company spearheads the creation of cutting-edge medical technologies, particularly in regenerative medicine and gene therapy, to combat conditions like obstructive arteriosclerosis, retinitis pigmentosa, and HIV/AIDS. Their innovative contributions include the Sendai virus vector and the CytoTune-iPS kit, designed for generating induced pluripotent stem cells. Furthermore, I'rom assists medical institutions with clinical trial execution and delivers extensive support for the development of novel drugs and medical equipment, with a focus on cancer, rare, and intractable diseases. The company also oversees the establishment and operation of clinic malls. Founded in Tokyo in 1997, it was formerly known as I'Rom Holdings Co., Ltd. until its name change in July 2015.
Aksjekurs
$18.20
Sist synkronisert: 2025-05-09
Markedsverdi
$220.35M
Endring (1 dag)
-5.34%
Endring (1 år)
0.00%
Land
JP
Handel I'rom Group Co., Ltd. (2372)

Kategori

P/S-forhold for I'rom Group Co., Ltd. (2372)
P/S-forhold per September 2026 TTM: 1.90
Ifølge I'rom Group Co., Ltd. sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/S-forhold (TTM) 1.90. Ved slutten av 2023 hadde selskapet et P/S-forhold på 1.25.
P/S-historikk for I'rom Group Co., Ltd. fra 2005 til 2026
P/S-forhold ved hvert års slutt
År P/S-forhold Endre
2026 (TTM) 1.90 51.10%
2024 1.26 0.87%
2023 1.25 -15.88%
2022 1.48 -34.86%
2021 2.28 58.49%
2020 1.44 -14.94%
2019 1.69 -58.83%
2018 4.10 34.43%
2017 3.05 0.72%
2016 3.03 -30.41%
2015 4.35 140.88%
2014 1.81 132.09%
2013 0.78 240.36%
2012 0.23 65.48%
2011 0.14 -3.56%
2010 0.14 -29.13%
2009 0.20 -69.69%
2008 0.67 -38.50%
2007 1.08 -79.63%
2006 5.32 -65.80%
2005 15.57 0.00%
P/S-forhold for lignende selskaper eller konkurrenter